Western Regional Medical Center
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Western Regional Medical Center sits in the top decile of US sponsors by registered trial count (#842 of 15,751 sponsors by registered trial count).
Western Regional Medical Center: 17 sponsored US clinical trials, none currently recruiting.
Western Regional Medical Center sponsors 17 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
Western Regional Medical Center ranks in the top decile of sponsors by registered trial count (#842 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
17 total, page 1 of 1
A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas
NCT02868892
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
NCT02423954
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
NCT02331251
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
NCT02318901
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
NCT02297087
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
NCT02414776
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
NCT02345772
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
NCT01936974
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
NCT01860040
Capecitabine With Digoxin for Metastatic Breast Cancer
NCT01887288
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
NCT01851174
Fasting on Newly Diagnosed Breast Cancer
NCT02379585
Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
NCT01937507
Interleukin-2 in Metastatic Kidney Cancer
NCT01702909
Interleukin-2 in Metastatic Melanoma
NCT01702896
Dacarbazine and Carmustine in Metastatic Melanoma
NCT01692691
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer
NCT01658813
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 10 |
How the Western Regional Medical Center early-phase archive is shaped
17 indexed studies, none listed as recruiting (0% open); 1 completed (6%).
Phase mix: 0 late (III/IV) vs 16 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.